Advertisement

Search Results for "Anticoagulant Dose"

04:10 EDT 18th May 2013 | BioPortfolio

Original Source: Heparin Sodium in Dextrose [B. Braun Medical Inc.]

Heparin Sodium in 5% Dextrose Injection

Matching Channels

Anticoagulant drugs

Thimerosal Preservative

Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials (vials containing more than one dose) of some vaccines to prevent the growth of ger...

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Kadcyla (ado-trastuzumab emtansine)

Kadcyla™ (ado-trastuzumab emtansine or T-DM1) for the treatment of people with HER2-positive metastatic breast cancer (mBC) who have received prior treatment with Herceptin® (trastuzumab)...

Prostate Cancer

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or...

Matching News

FDA OKs anticoagulant used with Arteriocyte's stem cell system

Arteriocyte has secured FDA approval for an anticoagulant solution used in conjunction with the company's Magellan device.  -More- 

Regado Biosciences raises $51M for anticoagulant trial

Regado Biosciences will advance Phase III trials of its anticoagulant REG1 using $51 million raised in a Series E round of fi -More- 

FDA OKs use of anticoagulant in stem cell collection

Arteriocyte has secured FDA approval for the use of an anticoagulant solution with the company's stem cell collection device. -More- 

Anticoagulant Drugs For Atrial Fibrillation - Safety Indicators Confirmed

A new study by medical scientists coordinated from the University of Manchester has for the first time used patients' results to establish that "safety indicators" for people taking anticoagulant drug...

FDA clears Arteriocyte Anticoagulant Citrate Dextrose Solution

The US Food and Drug Administration (FDA) has cleared Arteriocyte Medical Systems' 50cc volume of Anticoagulant Citrate Dextrose Solution, USP (ACD-A) for use with its Magellan Platelet Separation sys...

Anticoagulant Boosts Benefit of Antiplatelet After PCI (CME/CE)

(MedPage Today) -- Add-on anticoagulant therapy after stent deployment for acute coronary syndromes significantly reduced the risk of stent thrombosis and mortality in patients already receiving dual...

Anticoagulant Boosts Benefit of Antiplatelet After Stenting (CME/CE)

(MedPage Today) -- Add-on anticoagulant therapy after stent deployment for acute coronary syndromes significantly reduced the risk of stent thrombosis and mortality in patients already receiving dual...

BioInvent cuts workforce after anticoagulant disappointment

BioInvent cuts workforce after anticoagulant disappointment

Matching PubMed Articles

New anticoagulant drugs for atrial fibrillation : Feasibility and necessity of monitoring.

Two novel oral anticoagulants, namely the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitor rivaroxaban, have recently been approved for treatment of atrial fibrillation. They di...

Non-recovery of ACT in a patient with heparin-induced thrombocytopenia type II during mitral valve replacement using argatroban anticoagulation.

Argatroban was used as the anticoagulant during cardiopulmonary bypass (CPB) in a patient with heparin-induced thrombocytopenia (HIT) type II undergoing mitral valve replacement. Dosage was reduced be...

Long-term anticoagulant effects of CYP2C9 and VKORC1 genotypes in phenprocoumon users.

Anticoagulant treatment with phenprocoumon is challenging because of the narrow therapeutic range and the wide inter- and intra-patient variability in dose response. Frequent monitoring of the interna...

Sulfonation and anticoagulant activity of fungal exocellular β-(1→6)-d-glucan (lasiodiplodan).

An exocellular β-(1→6)-d-glucan (lasiodiplodan) produced by a strain of Lasiodiplodia theobromae (MMLR) grown on sucrose was derivatized by sulfonation to promote anticoagulant activity. The struct...

Managing Bleeding Complications in Patients Treated with the Old and the New Anticoagulants.

An increasing number of patients receive anticoagulant therapy to prevent and treat arterial or venous thromboembolism. The major complication of anticoagulant therapy is the increase of the individua...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement